SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(D) OF THE
 
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported):  June 25, 2008
 
INTERNATIONAL STEM CELL, COPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
 
000-51891
 
20-4494098
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification
Number)
 
 
2595 Jason Court, Oceanside, California 92056
(Address of principal executive offices, including zip code)
 
(760) 940-6383
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CAR 240.13e-4(c))
 

 
 
 
 
ITEM 8.01        Other Events.
 
International Stem Cell Corporation (OTCBB:ISCO) announced today that is has entered into an agreement with BioTime, Inc., and BioTime’s wholly owned subsidiary Embryome Sciences, Inc., to jointly produce and distribute hundreds of new standardized human and animal stem cell lines along with corresponding data and regents.
 

 
 (d)                                  EXHIBITS
 
Exhibit No.
 
Exhibit Description
     
99.1
 
 Press Release, dated June 25, 2008
     
     
     
 
 
 
 
2
 
 

 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
International Stem Cell Corporation
   
   
 
By:
/s/ William B. Adams
 
   
William B. Adams
   
Chief Financial Officer
     
   
Dated: June 25, 2008
 
 
 
 
 
3
 
 

 
EXHIBIT INDEX
 
Exhibit No.
 
Exhibit Description
     
99.1
 
Press Release, dated June 25, 2008
     
     
     
     
     
 
 
 
4

International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more International Stem Cell (QB) Charts.
International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more International Stem Cell (QB) Charts.